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DObjective: There is debate whether primary or delayed sternal closure is the best strategy after stage 1 palliation
for hypoplastic left heart syndrome. We describe center variation in delayed sternal closure after stage 1 palliation
and associated outcomes.
Methods: Society of Thoracic Surgeons Congenital Database participants performing stage 1 palliation for hy-
poplastic left heart syndrome from 2000 to 2007 were included. We examined center variation in delayed sternal
closure and compared in-hospital mortality, prolonged length of stay (length of stay>6 weeks), and postoperative
infection in centers with low (25% of cases), middle (26%–74% of cases), and high (75% of cases) delayed
sternal closure use, adjusting for patient and center factors.
Results: There were 1283 patients (45 centers) included. Median age at surgery was 6 days (interquartile range,
4–9 days), and median weight at surgery was 3.2 kg (interquartile range, 2.8–3.5 kg); 59% were male. Delayed
sternal closure was used in 74% of cases (range, 3%–100% of cases/center). In centers with high (n ¼ 23) and
middle (n ¼ 17) versus low (n ¼ 5) delayed sternal closure use, there was a greater proportion of patients with
prolonged length of stay and infection, and a trend toward increased in-hospital mortality in unadjusted analysis.
In multivariable analysis, there was no difference in mortality. Centers with high and middle delayed sternal clo-
sure use had prolonged length of stay (odds ratio, 2.83; 95% confidence interval, 1.46–5.47; P ¼ .002 and odds
ratio, 2.23; confidence interval, 1.17–4.26; P¼ .02, respectively) and more infection (odds ratio, 2.34; confidence
interval, 1.20–4.57; P ¼ .01 and odds ratio, 2.37; confidence interval, 1.36–4.16; P ¼ .003, respectively).
Conclusion: Use of delayed sternal closure after stage 1 palliation varies widely. These observational data sug-
gest that more frequent use of delayed sternal closure is associated with longer length of stay and higher postop-
erative infection rates. Further evaluation of the risks and benefits of delayed sternal closure in the management of
these complex infants is necessary. (J Thorac Cardiovasc Surg 2010;139:1205-10)Delayed sternal closure (DSC) after stage 1 palliation for
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The Journal of Thoracic and Carmonary bypass and characterized by increased vascular per-
meability, generalized edema, impaired pulmonary function,
coagulopathy, and cardiac dysfunction.1 Sternal closure im-
mediately after surgery can be associated with cardiac com-
pression, decreased ventricular compliance, and reduced
cardiac output, further compromising hemodynamic and re-
spiratory status.2,3 Thus, the aim of DSC is to minimize post-
operative hemodynamic and respiratory instability, and to
provide ready access to sites of persistent bleeding. DSC
may be used routinely, per surgeon or center preference,
or selectively, secondary to concern for hemodynamic insta-
bility after sternal closure.
However, outcomes associated with DSC are unclear, and
a recent survey suggested significant variation in use of DSC
after stage 1 palliation.4 Single-center studies have reported
conflicting results regarding the impact of DSC on out-
comes, including survival to hospital discharge and morbid-
ities such as postoperative infection.5-14 These studies have
been limited by small sample size and in some cases lack of
appropriate control groups.
The purpose of this study was to describe center variation
in the use of DSC after stage 1 palliation for HLHS and to
evaluate postoperative outcomes associated with DSC usingdiovascular Surgery c Volume 139, Number 5 1205
Abbreviations and Acronyms
CI ¼ confidence interval
DSC ¼ delayed sternal closure
HLHS ¼ hypoplastic left heart syndrome
OR ¼ odds ratio
STS ¼ Society of Thoracic Surgeons
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Surgery Database.FIGURE 1. Distribution of center use of DSC.MATERIALS AND METHODS
Data Source
As previously described, the STS Congenital Heart Surgery Database
collects operative and perioperative data on all patients undergoing congen-
ital heart surgery at participating centers.15 Data collected include demo-
graphics, diagnosis, noncardiac abnormalities, preoperative factors,
intraoperative details, surgical procedure performed, postoperative compli-
cations, and in-hospital mortality. The Duke Clinical Research Institute
serves as the data collection and management organization for the STS Na-
tional Databases. This study was approved by the Duke Institutional Review
Board.
Study Population
Infants who underwent stage 1 palliation (Norwood procedure with
modified Blalock–Taussig shunt or right ventricle to pulmonary artery
conduit) for HLHS between January 2000 and December 2007 were in-
cluded. Centers with more than 15% missing data on mortality, length of
stay, or postoperative complications, and those with less than 5 eligible
cases were excluded. Individual patients (n ¼ 7) from remaining centers
with missing data on mortality or length of stay were then excluded,
leaving a final population of 1283 patients from 45 centers. Missing
data for other variables in the final study population were rare (<0.8%
for all).
Data Collection
Data on use of DSC were collected. Of note, the STS database does
not distinguish between ‘‘routine’’ versus ‘‘selective’’ DSC. Patient de-
mographic information (age, weight, length, and gender) and data on
any noncardiac abnormalities were collected, as defined in the database
by asplenia, polysplenia, Down syndrome, Turner syndrome, DiGeorge,
Williams–Beuren syndrome, Alagille syndrome, 22q11 deletion, rubella,
Marfan syndrome, or any other chromosomal/syndromic abnormality.
Data collected regarding preoperative factors included preoperative shock,
acidosis, arrhythmia, mechanical circulatory support (use of extracorpo-
real membrane oxygenation or ventricular assist device), mechanical ven-
tilatory support (of note, the database does not distinguish between
mechanical ventilatory support required for respiratory failure vs that
used during transport or in routine preoperative management), renal fail-
ure, sepsis, and neurologic deficit. Operative data collected included dura-
tion of cardiopulmonary bypass, crossclamp, and circulatory arrest. The
data from the era of collection did not specify the use of regional cerebral
perfusion. Postoperative data collected included infection, length of stay,
and in-hospital mortality. Postoperative infection included sepsis (the cur-
rent definition of which in the database requires a positive blood culture
and excludes line infection), mediastinitis, wound infection, wound dehis-
cence, and endocarditis. Data on center characteristics were also collected,
including center region and annual surgical volume of stage 1 palliation
for HLHS.1206 The Journal of Thoracic and Cardiovascular SurAnalysis
Data were summarized using frequencies and percentages for categoric
variables and median and interquartile range for continuous variables. Cen-
ters were characterized on the basis of the proportion of cases at each center
for which DSC was used: low (25% of cases), middle (26%–74% of
cases), and high (75% of cases). Patient and center characteristics were
compared across the DSC groups using chi-square and Kruskal–Wallis tests
for categoric and continuous variables, respectively. The relationship be-
tween preoperative factors (any of above) and cardiopulmonary bypass
time was evaluated using the Wilcoxon rank-sum test. A generalized esti-
mating equations logistic regression analysis was used to evaluate the rela-
tionship between center average annual volume of stage 1 palliations
performed for HLHS and DSC use.
Outcomes associated with DSC were evaluated using a center-level anal-
ysis in an attempt to minimize the impact of patient confounders and to com-
pare outcomes at centers with ‘‘routine’’ or elective use of DSC versus those
that did not use DSC as frequently. In-hospital mortality, prolonged postop-
erative length of stay (defined as length of stay>6 weeks, which was the
upper quartile of length of stay for the entire cohort: median, 22 days; inter-
quartile range, 13–41 days) and postoperative infection (as defined above)
were compared across centers with low, middle, and high DSC use in uni-
variable and multivariable logistic regression, adjusting for patient age,
weight, preoperative factors (as listed above), year of surgery, and center
volume. The generalized estimating equations method was used to account
for correlation between outcomes of patients at the same center. Missing
data were imputed as ‘‘not present’’ for categoric variables, which was
the most common value, or the median of non-missing values for continu-
ous variables. Finally, a sensitivity analysis was performed to evaluate the
impact of preoperative factors on outcome. Unadjusted and adjusted odds
ratios (ORs) and 95% confidence intervals (CIs) are presented. All analyses
were conducted using SAS version 8.2 (SAS Institute Inc, Cary, NC).RESULTS
A total of 1283 patients from 45 centers were included.
Median age at surgery was 6 days (4–9 days), and median
weight at surgery was 3.2 kg (2.8–3.5 kg); 59% were
male. DSC was used in 74% of cases overall (range, 3%–
100% of cases per center; Figure 1). Patient characteristics,gery c May 2010
TABLE 1. Patient characteristics
DSC use
Low Middle High
5 centers (n ¼ 111) 17 centers (n ¼ 406) 23 centers (n ¼ 766)
Patient characteristics
Age, d 8 (5–24) 6 (4–8) 6 (4–8)
Weight, kg 3.3 (2.9–3.8) 3.2 (2.8–3.5) 3.1 (2.8–3.5)
Gender, male 73 (65.8%) 240 (59.1%) 445 (58.1%)
Noncardiac abnormality/
syndrome
19 (17.1%) 75 (18.5%) 126 (16.5%)
Preoperative factors
Shock 5 (4.5%) 13 (3.2%) 32 (4.2%)
Acidosis 8 (7.2%) 44 (10.8%) 133 (17.4%)
Mechanical circulatory
support
0 (0.0%) 5 (1.2%) 7 (0.9%)
Mechanical ventilatory
support
24 (21.6%) 156 (38.4%) 338 (44.1%)
Renal failure 2 (1.8%) 8 (2.0%) 10 (1.3%)
Septicemia 3 (2.7%) 8 (2.0%) 12 (1.6%)
Neurologic deficit 1 (0.9%) 7 (1.7%) 8 (1.0%)
Operative data
CPB time, min 192 (143–266) 160 (137–193) 134 (79–169)
Crossclamp time, min 65 (47–95) 55 (42–71) 46 (1–62)
Circulatory arrest
time, min*
12 (0–41) 7 (0–34) 34 (4–48)
DSC, Delayed sternal closure; CPB, cardiopulmonary bypass. *Use of regional cerebral perfusion is not currently captured in the STS Database.
TABLE 2. Unadjusted and adjusted odds ratios for outcomes
associated with center use of delayed sternal closure
Unadjusted Adjusted
OR (95% CI) P value OR (95% CI) P value
In-hospital mortality
DSC use:
Low Reference
Middle 1.90
(0.93–3.89)
.08 1.28
(0.80–2.07)
.31
High 1.63
(0.85–3.11)
.14 1.08
(0.68–1.71)
.74
Postoperative infection
DSC use:
Low Reference
Middle 2.82
(1.53–5.21)
.001 2.37
(1.36–4.16)
.003
High 2.75
(1.28–5.92)
.009 2.34
(1.20–4.57)
.01
Prolonged LOS
DSC use:
Low Reference
Middle 2.09
(1.07–4.05)
.03 2.23
(1.17–4.26)
.02
High 2.59
(1.37–4.91)
.004 2.83
(1.46–5.47)
.002
OR,Odds ratio;CI, confidence interval;DSC,delayed sternal closure;LOS, length of stay.
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Dpreoperative factors, and operative data in the low, middle,
and high DSC groups are displayed in Table 1. The weight
at surgery and presence of any noncardiac abnormality were
similar across groups. The distribution of various preopera-
tive factors was similar across groups as shown in Table 1,
with the exception of acidosis and preoperative mechanical
ventilatory support. In regard to operative data, those with
more frequent use of DSC had shorter cardiopulmonary by-
pass times (Table 1). The presence of any of the preoperative
factors listed in Table 1 was associated with shorter cardio-
pulmonary bypass time (145 minutes [93–178] vs 151 min-
utes [123–184], P< .0001).
On evaluation of center characteristics, there was no asso-
ciation between center average annual volume of stage 1 pal-
liations performed for HLHS and the proportion who
received DSC (P ¼ .1). There was no evidence of variation
in the frequency of DSC across geographic regions.
Unadjusted outcomes are shown in Table 2 and Figure 2.
In unadjusted analysis, there was a trend toward greater in-
hospital mortality and a significantly increased proportion
with postoperative infection and prolonged length of stay
in the middle and high DSC groups compared with the
low DSC group. Length of stay was 17 days (8–26 days)
in the low DSC group, 21 days (12–40 days) in the middle
DSC group, and 24 days (14–43 days) in the high DSC
group (P< .001). Information concerning type of postoper-
ative infection is shown in Table 3.The Journal of Thoracic and Cardiovascular Surgery c Volume 139, Number 5 1207
FIGURE 2. Unadjusted outcomes associated with center use of DSC.
Comparison of the middle and high DSC groups versus low DSC group:
P ¼ .08 and P ¼ .14 for mortality, P ¼ .001 and P ¼ .009 for infection,
and P ¼ .03 and P ¼ .004 for prolonged length of stay, respectively. Lines
extending from the bars indicate 95% CIs. DSC, Delayed sternal closure;
LOS, length of stay.
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DIn multivariable analysis, there was no significant differ-
ence in in-hospital mortality among groups, but postopera-
tive infection and prolonged length of stay were
significantly greater in the middle and high DSC groups
compared with the low DSC group (Table 2).
To evaluate the impact of preoperative factors on outcome,
preoperative factors were removed from the models and the
analysis was repeated, with similar results (vs Table 2):
in-hospital mortality (middle DSC group: OR, 1.35; 95%
CI, 0.83–2.22; P ¼ .23; and high DSC group: OR, 1.21; CI,
0.77–1.90; P ¼ .40), infection (middle DSC group: OR,
2.49; CI, 1.40–4.40; P ¼ .002; and high DSC group: OR,
2.56; CI, 1.30–5.01; P ¼ .006), and prolonged length of
stay (middle DSC group: OR, 2.30; CI, 1.17–4.52; P ¼ .02;
and high DSC group: OR, 2.99; CI, 1.51–5.92; P ¼ .002).DISCUSSION
There is debate regarding the optimal timing of sternal
closure after stage 1 palliation for infants with HLHS. Al-
though it is hypothesized that DSC may promote greater he-
modynamic and respiratory stability in the postoperativeTABLE 3. Type of postoperative infection
Low
5 centers (n ¼ 111) 17 ce
Wound dehiscence 0 (0%)
Wound infection 3 (2.7%)
Postoperative sepsis 5 (4.5%)
Mediastinitis 1 (0.9%)
Postoperative endocarditis 0 (0%)
DSC, Delayed sternal closure.
1208 The Journal of Thoracic and Cardiovascular Surperiod, outcomes associated with this approach are unclear.
By evaluating 1283 infants with HLHS, we found that use of
DSC after stage 1 palliation varied widely among 45 US cen-
ters. More frequent use of DSC was associated with pro-
longed length of stay and higher rates of postoperative
infection. DSC was not significantly associated with in-hos-
pital mortality.
Survival after staged palliation for patients with HLHS
has improved significantly during the past 2 decades.16-19
However, evidence to guide optimal care in this patient pop-
ulation is still evolving. A recent survey of centers caring for
infants with HLHS suggested that perioperative care varied
widely by center, including differences in models of care de-
livery, operative techniques, medications used, feeding reg-
imens, and type of monitoring.4 Wide variations in practice
may reflect the lack of evidence to define best practices.
This prior survey also suggested variation in use of DSC
after stage 1 palliation, which was confirmed in our study.4
We did not find any correlation between the use of DSC and
center characteristics. In regard to patient characteristics, we
found that centers who used DSC more frequently tended to
report a higher prevalence of factors, such as acidosis and
preoperative mechanical ventilatory support. This may re-
flect differences in patient preoperative status or coding of
these variables. Of note, the database does not distinguish
between mechanical ventilation required for respiratory fail-
ure versus that used in the routine preoperative management
of these infants. However, one may hypothesize that because
of the presence of these factors, these patients were ‘‘sicker’’
going into surgery, leading to longer cardiopulmonary by-
pass times, greater postoperative edema, and more frequent
use of DSC. Previous studies have suggested that longer car-
diopulmonary bypass times are associated with greater cap-
illary leak and postoperative inflammation, and greater use
of DSC.20-22 However, we found that patients with preoper-
ative ‘‘risk’’ factors actually had shorter cardiopulmonary
bypass times. Centers with more frequent use of DSC also
had shorter cardiopulmonary bypass times. In addition, in
a sensitivity analysis to evaluate the impact of preoperative
factors on outcome, we found similar results whether or
not these factors were included in our models. Thus, our
data suggest that the presence of these preoperative factorsDSC use
Middle High
nters (n ¼ 406) 23 centers (n ¼ 766) P value
10 (2.5%) 7 (0.9%) .04
16 (3.9%) 32 (4.2%) .76
55 (13.6%) 95 (12.4%) .03
2 (0.5%) 14 (1.8%) .15
1 (0.3%) 3 (0.4%) .76
gery c May 2010
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Dor longer duration of cardiopulmonary bypass does not lead
to more frequent use of DSC, and that these preoperative fac-
tors do not seem to affect the relationship between DSC and
outcome. Other factors not captured in the STS Database,
such as hemodynamic status at the conclusion of surgery,
experience of ICU staff in managing infants who have un-
dergone primary sternal closure, and availability of 24-
hour in-house surgical support, may affect center or surgeon
preference for primary versus DSC. In addition, other preop-
erative variables, including variations in anatomic substrate
such as the presence of aortic atresia or a restrictive atrial
septum, may also affect outcome.9,23
Results of prior studies evaluating outcomes associated
with DSC are conflicting. Studies of DSC in infants and chil-
dren undergoing congenital heart surgery for a variety of de-
fects have reported increased mortality associated with
DSC.5,6 However, in these studies, DSC was only performed
in patients who were hemodynamically unstable. Therefore,
higher mortality in this group may be expected. In studies fo-
cusing on patients undergoing stage 1 palliation, some have
found DSC to be associated with increased mortality,
whereas others have not found a significant relationship.7-9
In our analysis, we did not find a significant relationship
between in-hospital mortality and DSC. Despite potential
alterations in hemodynamic status associated with primary
sternal closure, and hypothesized benefits of DSC, a survival
benefit was not evident in our analysis.2,3
In contrast, we did find that use of DSC was associated
with increased postoperative morbidity, including infection
and prolonged length of stay. Prior studies regarding the re-
lationship between DSC and postoperative infection have
had mixed results. Several studies have reported no increase
in mediastinitis or bloodstream infections associated with
the use of DSC.10,11 However, others have shown an in-
crease in gram-negative mediastinitis and surgical site infec-
tions.12-14 Our data show the higher rate of infection is
primarily related to bloodstream infections. Previous studies
evaluating the relationship of DSC with length of stay are
limited. A prior single-center study in the arterial switch
population reported no difference in survival, postoperative
length of stay, or postoperative infection associated with
DSC.24 This study was limited by small sample size (n ¼
52). It is likely that the increased frequency of postoperative
infection found in our study is related to the prolonged
length of stay. Postoperative infection has been shown to
be associated with prolonged length of stay and increased
mortality.13 Because of the limitations of the database, we
were not able to evaluate the impact of DSC on duration
of mechanical ventilation; however, it is likely that use of
DSC is associated with longer duration of intubation, which
may also affect length of stay. Alternatively, it is possible
that length of stay was affected by other factors not related
to DSC, such as postoperative feeding difficulties, the man-
agement of which may vary by center. Such variation wouldThe Journal of Thoracic and Carnot lead to a spurious association between DSC and length
of stay unless these factors differed systematically across
the different categories of DSC. In addition, to reduce the
potential for confounding by center-level factors, our risk
model explicitly adjusted for hospital-level variables, in-
cluding center volume. Finally, our analytic strategy ac-
counts for unexplained between-hospital variation by
treating observations within a hospital as clustered (corre-
lated) observations. Perioperative morbidities, such as pro-
longed length of stay, also may have an impact on longer-
term outcomes, because prior studies have shown prolonged
hospital stay to be an independent predictor of future neuro-
developmental status in patients with HLHS.25
LIMITATIONS
This study is subject to the limitations associated with all
observational investigations, including selection bias and
the potential impact of confounders. We performed a cen-
ter-level analysis in an attempt to minimize the impact of pa-
tient confounders and adjusted for patient and center factors
in addition to accounting for within-center clustering of out-
comes in our models. We also performed a sensitivity anal-
ysis to further evaluate the potential impact of patient
preoperative factors on outcome.
This study is also subject to the limitations of data col-
lected. We were unable to evaluate elective versus emer-
gency use of DSC because this is not defined in the
database. However, using a center-level analysis did allow
us to compare outcomes in those with ‘‘routine’’ or elective
(high) use of DSC versus those who did not use DSC as fre-
quently. We were also unable to evaluate the impact of du-
ration of time the chest is open after surgery on outcomes
because this information is not uniformly captured in the da-
tabase currently. The database is also limited in that institu-
tions may differ in their coding of different variables. More
uniform definitions of variables were added to the database
in 2005; however, these may still be interpreted differently
by different institutions. In addition, we were not able to
evaluate the impact of factors such as variations in anatomic
substrate, hemodynamic status at the conclusion of surgery,
perioperative antibiotic or corticosteroid use, and center
model of postoperative care on the relationship between
DSC and outcome because these variables are not collected
in the database. Finally, although this represents the largest
study to date evaluating DSC in this population, our sample
size may have limited our power to detect certain differences
among groups.
CONCLUSIONS
This multicenter study is the largest to date evaluating use
of DSC after stage 1 palliation for patients with HLHS. We
found that use of DSC varies widely, although the majority
of centers use DSC in more than half of cases. This observa-
tional study suggests that more frequent use of DSC isdiovascular Surgery c Volume 139, Number 5 1209
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Dassociated with no difference in survival, greater postopera-
tive morbidity, including prolonged length of stay, and
higher rates of postoperative infection, primarily related to
sepsis. Further evaluation of the risks and benefits of DSC
in the management of these complex infants is warranted,
particularly in cases involving elective use of DSC. Given
the wide variation in practice of DSC by institution and po-
tential variations in other aspects of care for these infants,
a trial performed in this area may need to use stratification
of randomization by institution or the implementation of
standardized management protocols across institutions.
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